Approval Order StatementApproval for the addition of a new trade name. The device, as modified, will be marketed under the trade name hemostase mph and is indicated for use in surgical procedures (except neurological and ophthalmic) as an adjunctive hemostatic device to assist when control of capillary, venous, and arterial bleeding by pressure, ligature and other conventional procedures are ineffective or impractical.